Industry News
Melbourne Uni cuts deal with Janssen-Cilag to research respiratory infection drug
The University of Melbourne and Janssen-Cilag have signed a collaboration agreement covering research into drug candidates for acute respiratory infections. [ + ]
Starpharma technology improves anti-cancer drug 40-fold
Animal trials of Starpharma's (ASX:SPL) dendrimer-docetaxel chemotherapy product show the formulation is potentially far more effective at targeting tumours than the conventional formula. [ + ]
Next generation sequencing reveals pancreatic cancer’s secrets
A new genomic study shows pancreatic cancer is not just a single cancer but has many variations, requiring potentially many different treatments. [ + ]
AusBiotech 2012 special feature: Found in translation
Here are five ways that are currently being discussed that could transform the commercialisation of medical research in Australia. [ + ]
Reducing the immunity of cancer cells
Recently published research by a team based at La Trobe University Bendigo shows partial success in bringing the fight against cancer one small step closer to success. [ + ]
Australian Synchrotron and ANSTO join forces to advance Australian science
The Australian Nuclear Science and Technology Organisation (ANSTO) will become the new operator of the Australian Synchrotron from 1 January 2013, bringing two of Australia’s most significant pieces of scientific infrastructure together and advancing scientific outcomes for the nation. [ + ]
Beautiful physics: tying knots in light
Dr Anton Desyatnikov from the Nonlinear Physics Centre at The Australian National University is part of an international team of scientists who are designing knots in light. [ + ]
Tertiary tech transfer opportunities to be showcased at AusBiotech
UniQuest will promote the business benefits of partnering with the latest research innovations and expertise from Australian universities at this year’s AusBiotech conference in Melbourne from 30 October to 2 November. [ + ]
Abraxane performs well in metastatic melanoma
Specialised Therapeutics Australia (STA) has revealed some positive results from a phase III trial of nanoparticle chemotherapy Abraxane in metastatic melanoma. [ + ]
Pharmaxis' Bronchitol to get NHS listing in UK
Pharmaxis (ASX:PXS) has received the final approval required to have its Bronchitol cystic fibrosis treatment cleared for reimbursement by the UK National Health Service. [ + ]
Major flaw found in standard approach to gene expression analysis
Common assumptions employed in the generation and interpretation of data from global gene expression analyses can lead to seriously flawed conclusions about gene activity and cell behaviour, according to Whitehead Institute researchers. [ + ]
Birth of calf expected after ‘handmade cloning’
Professor Gábor Vajta has been working on a handmade cloning technique in collaboration with Australian Reproductive Technologies. [ + ]
Protein regulation and intellectual disability
While many intellectual disabilities are caused directly by a genetic mutation in the protein coding part of genes, genetics researchers at the University of Adelaide have found a case where the cause is actually outside the gene, in the regulation of proteins. [ + ]
Breakthrough research into pancreatic cancer gene mutations
A large-scale international study into pancreatic cancer has discovered that the cancer is not just one disease, but many. [ + ]
Have you registered for biotech’s industry event of the year?
Prominent biotechnology individuals from across Australia and around the world will join the conference for agenda-setting programs, world-class networking and partnering opportunities, and over 150 industry-leading speakers in more than 30 sessions. [ + ]
